Blu – Pagina 293 – AMD

Blu

Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.

Settembre 27, 2017

Increased Hazard of Myocardial Infarction With Insulin Provision Therapy in Actively Smoking Patients With Diabetes Mellitus and Stable IschemicHeart Disease: The BARI 2D (Bypass Angioplasty RevascularizationInvestigation 2 Diabetes) Trial

Khan AA, Chung MJ, Novak E, et al
J Am Heart Assoc 2017;6:e005946

Leggi

Settembre 27, 2017

Diabetes Mellitus and Control of Cardiovascular Disease Risk Factors: A Challenge to Improve Usual Care

Wilson PWF, Gagnon D
Circulation 2017;136:1204-6

Leggi

Settembre 25, 2017

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes

Holman RR, Bethel MA, Mentz, RJ, et al
NEJM 2017. September 14, 2017

Leggi

Settembre 25, 2017

PCSK9 Inhibition and Type 2 Diabetes

Lotta LA, Griffin SJ
Lancet Diabetes Endocrinol. Pub. online September 15, 2017

Leggi

Settembre 25, 2017

Cardiovascular Safety and Efficacy of the PCSK9 Inhibitor Evolocumab in Patients With and Without Diabetes and the Effect of Evolocumab on Glycaemia and Risk of New-Onset Diabetes: A Prespecified Analysis of the FOURIER Randomised Controlled Trial

Sabatine MS, Leiter LA, Wiviott SD, et al.
Lancet Diabetes Endocrinol. Pub. online September 15, 2017

Leggi

Settembre 25, 2017

Impact of Stroke Risk Factors on Ethnic Stroke Disparities Among Midlife Mexican Americans and Non-Hispanic Whites

Pate RCl, Sánchez BN, Morgenstern LB, et al.
Stroke 2017. Pub online September 21, 2017

Leggi

Settembre 25, 2017

Residual Angina After Elective Percutaneous Coronary Intervention in Patients With Diabetes Mellitus

Grodzinsky A, Kosiborod M, Tang F, et al.
Circ Cardiovasc Qual Outcomes. Pub. online September 13, 2017.

Leggi

Settembre 25, 2017

Dipeptidyl Peptidase-4 Inhibitors and Risk of Heart Failure in Patients With Type 2 Diabetes Mellitus: A Population-Based Cohort Study

Kim Y-G, Yoon D, Park S, et al.
Circ Heart Fail. Pub. online September 12, 2017

Leggi

Settembre 25, 2017

Effects of the Selective Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin on Vascular Function and Central Hemodynamics in PatientsWith Type 2 Diabetes Mellitus

Striepe K, Jumar A, Ott C, et al.
Circulation 2017;136(12):1167-9

Leggi

Settembre 20, 2017

Continuous Glucose Monitoring in Pregnant Women With Type 1 Diabetes (CONCEPTT): A Multicentre International Randomised Controlled Trial

Feig DS, Donovan LE, Corcoy R, et al. on behalf of the show CONCEPTT Collaborative Group
The Lancet. Pub.online15 September 2017

Leggi